GO:0016324; C:apical plasma membrane; IBA:RefGenome
GO:0009986; C:cell surface; IBA:RefGenome
GO:0005737; C:cytoplasm; IBA:RefGenome
GO:0005615; C:extracellular space; IDA:UniProt
GO:0070062; C:extracellular vesicular exosome; IDA:UniProtKB
GO:0005796; C:Golgi lumen; TAS:Reactome
GO:0005887; C:integral component of plasma membrane; TAS:ProtInc
GO:0000790; C:nuclear chromatin; IDA:BHF-UCL
GO:0031982; C:vesicle; IDA:UniProtKB
GO:0002039; F:p53 binding; IPI:BHF-UCL
GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IDA:BHF-UCL
GO:0003712; F:transcription cofactor activity; IDA:BHF-UCL
GO:0044267; P:cellular protein metabolic process; TAS:Reactome
GO:0071300; P:cellular response to retinoic acid; IEA:Ensembl
GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; IDA:BHF-UCL
GO:0006978; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; IDA:BHF-UCL
GO:0030855; P:epithelial cell differentiation; IEA:Ensembl
GO:0007565; P:female pregnancy; IEA:Ensembl
GO:1902166; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IDA:BHF-UCL
GO:0010944; P:negative regulation of transcription by competitive promoter binding; IDA:BHF-UCL
GO:0016266; P:O-glycan processing; TAS:Reactome
GO:0090240; P:positive regulation of histone H4 acetylation; IDA:BHF-UCL
GO:0036003; P:positive regulation of transcription from RNA polymerase II promoter in response to stress; IDA:BHF-UCL
GO:0043687; P:post-translational protein modification; TAS:Reactome
GO:0043618; P:regulation of transcription from RNA polymerase II promoter in response to stress; IDA:BHF-UCL
GO:0001666; P:response to hypoxia; IEA:Ensembl